Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 168

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 19
Chunk 168
---
 95                 22                 43  
  Repayment                                                       352                467                467  

Total
negative cash flows in respect of leasing for the years ended December 31, 2024, 2023 and 2022 are approximately NIS 447 489 510

F-29

SAVERONE
2014 LTD.

NOTES
TO THE FINANCIAL STATEMENTS (CONT.)

(New
Israeli Shekels in thousands, except per share and share data)

Note
9 - Leasing (Cont.)

  Analysis of contractual payment dates of leasing liability at December 31, 2024:  
 ────────────────────────────────────────────────────────────────────────────────────

  Up to a year          469  
  1-2 years             469  
  2-3                   235  
  Total               1,173  
  Discount             ( 98  
  Net                 1,075  

Note
10 - Other current liabilities

  Composition:  

                                                    As                        
                                       of December 31,                        
                                                  2024                        
 ──────────────────────────────────────────────────────────────────────────────
  Employees and                                             1,868      1,574  
  Accrued expenses                                          1,123        468  
  Others                                                        -          -  
                                                            2,991      2,042  

  (*)      Includes balance of NIS 125 in respect of management fees to related party as of December 31, 2024 (see Note 18A below).  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Note
11 - Liability in respect of government grants

  Since the Inception Date, the Company has received grants in respect of participation in research and development from the IIA, in a total amount of NIS 1.7 million. In return, the Company unde...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

The
Company recognized a liability in respect of these grants at the initial recognition date in an amount equal to the fair value of the
liability, based on the present value of the royalty payments payable to the IIA as a percentage of sales, discounted at a discount rate
of 20

F-30

SAVERONE
2014 LTD.

NOTES
TO THE FINANCIAL STATEMENTS (CONT.)

(New